Trastuzumab deruxtecan yields promising results in HER2-positive breast cancer patients pretreated with TDM-1

Myeloma highlights from ASH 2019

Weekly wKRd-D in newly diagnosed multiple myeloma achieves unprecedented results

FLT3-inhibition in infants with acute lymphoblastic leukaemia

Chronic lymphocytic leukaemia highlights from ASH 2019

Benefits of apixaban among venous thromboembolism patients with active cancer

Inotuzumab ozogamicin and chemotherapy with or without blinatumomab in Philadelphia chromosone-negative ALL

Updates on REGN1979 in R/R B-cell non-Hodgkins lymphoma

Eligibility criteria in acute myeloid leukaemia clinical trials

Azacitidine plus nivolumab in older adults with AML or MDS

Precision medicine treatment in older AML: Results of Beat AML master trial

Older patients with non-Hodgkin lymphoma can be treated successfully with CAR T-cell therapy